Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
370 artigos
Leading neurologists argue that amyloid aggregation dynamics may be distorting how we read clinical trial results for Alzheimer's immunotherapies.
A multi-omics subspace-merging algorithm identifies biologically distinct AD subtypes, pointing toward personalized treatment strategies.
A newly identified GABAergic pathway in mice lets the brain toggle between updated and previous memories — a key insight for memory disorders.
MIT's self-organizing laser creates ultra-sharp brain images 25x faster, enabling real-time tracking of drugs crossing the blood-brain barrier.
New review maps how α-synuclein assays may detect Parkinson's before symptoms appear — and what stands between lab and clinic.
A landmark review argues neurodegeneration is driven by interacting misfolded proteins, not single culprits — reshaping diagnosis and treatment.
A new review reveals that disrupted mito-nuclear signaling may precede amyloid and tau pathology, opening fresh therapeutic targets for Alzheimer's.
A Framingham study of 2,844 adults links impaired endothelial function to higher Alzheimer's risk, brain shrinkage, and white matter damage.
A new AI classifier using just 15 proteins achieves 95.5% AUC accuracy across Alzheimer's, Parkinson's, FTD, and Lewy body dementia.
New research reveals how the brain decides which memories to link — and which to keep separate — with major implications for cognition and dementia.
New research links internalized stress and hopelessness to faster memory decline, pointing to a modifiable risk factor for cognitive aging.
New research reveals brain movement inside the skull is mechanically driven by abdominal contractions, not heartbeat or breathing.
